Anthem Biosciences Limited (ANTHEM) Stock Statistics & Valuation Metrics

Anthem Biosciences Limited has a market cap or net worth of INR 529.00B. The enterprise value is INR 480.69B.

Market Cap

INR 529.00B

Enterprise Value

INR 480.69B

Anthem Biosciences Limited has 563,663,940 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

563,663,940

Owned by Insiders

―

Owned by Institutions

1.03%

Anthem Biosciences Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 16.06%.

Return on Equity (ROE)

0.19

Return on Assets (ROA)

0.17

Return on Invested Capital (ROIC)

16.06%

Return on Capital Employed (ROCE)

0.23

Revenue Per Employee

9.31M

Profits Per Employee

2.59M

Employee Count

2,282

Asset Turnover

0.62

Inventory Turnover

9.87

The current PE Ratio of Anthem Biosciences Limited is 85.88. Anthem Biosciences Limited’s PEG ratio is 4.65.

PE Ratio

85.88

PS Ratio

25.80

PB Ratio

16.09

Price to FCF

192.11

Price to Operating Cash Flow

131.17

PEG Ratio

4.65

In the last 12 months, Anthem Biosciences Limited had revenue of 21.24B and earned 5.92B in profits. Earnings per share was 10.55.

Revenue

21.24B

Gross Profit

8.95B

Operating Income

7.00B

Pretax Income

8.24B

Net Income

5.92B

EBITDA

8.34B

Earnings Per Share (EPS)

10.55

In the last 12 months, operating cash flow was 6.34B and capital expenditures -3.25B, giving a free cash flow of 3.09B billion.

Operating Cash Flow

6.34B

Free Cash Flow

3.09B

Free Cash Flow per Share

4.88

Anthem Biosciences Limited pays an annual dividend of INR 2.00, resulting in a dividend yield of 0.21%

Dividend Per Share

INR 2.00

Dividend Yield

0.21%

Payout Ratio

15.57%

Free Cash Flow Yield

0.52%

Earnings Yield

1.16%

Beta

0.90

52-Week Price Change

34.11%

50-Day Moving Average

881.93

200-Day Moving Average

785.29

Relative Strength Index (RSI)

65.43

Average Volume (3m)

150.11K

Anthem Biosciences Limited upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 03, 2026

Next Earnings Date

Feb 11, 2027

Ex-Dividend Date

Jun 25, 2026

Anthem Biosciences Limited as a current ratio of 5.54, with Debt / Equity ratio of 1.77%

Current Ratio

5.54

Quick Ratio

5.15

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.26

Interest Coverage Ratio

101.50

In the past 12 months, Anthem Biosciences Limited has paid 2.32B in taxes.

Income Tax

2.32B

Effective Tax Rate

0.28

Anthem Biosciences Limited EV to EBITDA ratio is 61.80, with an EV/FCF ratio of 192.18.

EV to Sales

25.81

EV to EBITDA

61.80

EV to Free Cash Flow

192.18

EV to Operating Cash Flow

131.22

Anthem Biosciences Limited has INR 11.00B in cash and marketable securities with INR 1.10B in debt, giving a net cash position of INR 9.90B billion.

Cash & Marketable Securities

INR 11.00B

Total Debt

INR 1.10B

Net Cash

INR 9.90B

Net Cash Per Share

INR 17.57

Tangible Book Value Per Share

INR 48.99

Gross margin is 44.94%, with operating margin of 34.78%, and net profit margin of 30.00%.

Gross Margin

44.94%

Operating Margin

34.78%

Pretax Margin

41.51%

Net Profit Margin

30.00%

EBITDA Margin

41.76%

EBIT Margin

35.18%

The average price target for Anthem Biosciences Limited is INR 1,000.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

INR 1,000.00

Price Target Upside

6.79% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

-1.20%

EPS Growth Forecast

18.53%

Smart Score

―

AI Score

77